Paroxysmal supraventricular tachycardia historical perspective: Difference between revisions
Noha Elzeiny (talk | contribs) No edit summary |
Noha Elzeiny (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There is limited information about the historical perspective of [[PSVT]]. In January 1998 the first [[Epidemiology|epidemiologic]] study of the general population in the USA was published. [[Catheter ablation|Catheter-based radiofrequency ablation]] has improved the treatment of PSVT, since 1980S [[catheter ablation]] has improved progressively especially in terms of [[Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers|safety]] and [[specificity]]. | |||
==Historical Perspective== | ==Historical Perspective== | ||
* There is limited information about the historical perspective of PSVT. | * There is limited information about the historical perspective of [[PSVT]]. | ||
*In January 1998 the first epidemiologic study of the general population in USA was published <ref>Orejarena, L. A., Vidaillet, H., DeStefano, F., Nordstrom, D. L., Vierkant, R. A., Smith, P. N., & Hayes, J. J. (1998). Paroxysmal Supraventricular Tachycardia in the General Population. Journal of the American College of Cardiology, 31(1), 150–157. doi:10.1016/s0735</ref>. | *In January 1998 the first [[Epidemiological correlation|epidemiologic]] study of the general population in the USA was published <ref>Orejarena, L. A., Vidaillet, H., DeStefano, F., Nordstrom, D. L., Vierkant, R. A., Smith, P. N., & Hayes, J. J. (1998). Paroxysmal Supraventricular Tachycardia in the General Population. Journal of the American College of Cardiology, 31(1), 150–157. doi:10.1016/s0735</ref>. | ||
* Catheter-based radiofrequency ablation has improved the treatment of PSVT by precise ablation of the abnormal accessory pathway. First catheter ablations were in the early to mid-1980s, since then it has improved progressively especially in terms of safety and specificity <ref>Ghzally Y, Gerasimon G. Catheter Ablation. [Updated 2020 Feb 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470203/</ref>. | *[[Catheter ablation|Catheter-based radiofrequency ablation]] has improved the treatment of [[PSVT]] by precise [[ablation]] of the abnormal [[Accesory pathway|accessory pathway.]] First [[Catheter ablation|catheter ablations]] were in the early to mid-1980s, since then it has improved progressively especially in terms of [[Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers|safety]] and [[specificity]] <ref>Ghzally Y, Gerasimon G. Catheter Ablation. [Updated 2020 Feb 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470203/</ref>. | ||
==References== | ==References== | ||
Latest revision as of 20:40, 16 July 2020
|
Paroxysmal supraventricular tachycardia Microchapters |
|
Differentiating Paroxysmal supraventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Paroxysmal supraventricular tachycardia historical perspective On the Web |
|
American Roentgen Ray Society Images of Paroxysmal supraventricular tachycardia historical perspective |
|
FDA on Paroxysmal supraventricular tachycardia historical perspective |
|
CDC on Paroxysmal supraventricular tachycardia historical perspective |
|
Paroxysmal supraventricular tachycardia historical perspective in the news |
|
Blogs on Paroxysmal supraventricular tachycardia historical perspective |
|
Risk calculators and risk factors for Paroxysmal supraventricular tachycardia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Noha Elzeiny, M.B.B.Ch, M.Sc.[2]
Overview
There is limited information about the historical perspective of PSVT. In January 1998 the first epidemiologic study of the general population in the USA was published. Catheter-based radiofrequency ablation has improved the treatment of PSVT, since 1980S catheter ablation has improved progressively especially in terms of safety and specificity.
Historical Perspective
- There is limited information about the historical perspective of PSVT.
- In January 1998 the first epidemiologic study of the general population in the USA was published [1].
- Catheter-based radiofrequency ablation has improved the treatment of PSVT by precise ablation of the abnormal accessory pathway. First catheter ablations were in the early to mid-1980s, since then it has improved progressively especially in terms of safety and specificity [2].
References
- ↑ Orejarena, L. A., Vidaillet, H., DeStefano, F., Nordstrom, D. L., Vierkant, R. A., Smith, P. N., & Hayes, J. J. (1998). Paroxysmal Supraventricular Tachycardia in the General Population. Journal of the American College of Cardiology, 31(1), 150–157. doi:10.1016/s0735
- ↑ Ghzally Y, Gerasimon G. Catheter Ablation. [Updated 2020 Feb 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470203/